Last reviewed 2026-04-20 · How we verify

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN

Korea Health Industry Development Institute · FDA-approved active Small molecule Quality 0/100

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is a Small molecule drug developed by Korea Health Industry Development Institute. It is currently FDA-approved. Also known as: standard code for item: 200005676.

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is a marketed product developed by the Korea Health Industry Development Institute, with a key composition patent expiring in 2028. The drug's market position and primary indication are not specified, but it holds a competitive advantage due to its current market presence and patent protection. The primary risk is the patent expiry in 2028, which could lead to increased competition from generic versions.

At a glance

Generic name	SIHOGAYONGGOLMORYU TANG EXTRACT GRAN
Also known as	standard code for item: 200005676
Sponsor	Korea Health Industry Development Institute
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN CI brief — competitive landscape report
SIHOGAYONGGOLMORYU TANG EXTRACT GRAN updates RSS · CI watch RSS
Korea Health Industry Development Institute portfolio CI

Frequently asked questions about SIHOGAYONGGOLMORYU TANG EXTRACT GRAN

What is SIHOGAYONGGOLMORYU TANG EXTRACT GRAN?

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is a Small molecule drug developed by Korea Health Industry Development Institute.

Who makes SIHOGAYONGGOLMORYU TANG EXTRACT GRAN?

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is developed and marketed by Korea Health Industry Development Institute (see full Korea Health Industry Development Institute pipeline at /company/korea-health-industry-development-institute).

Is SIHOGAYONGGOLMORYU TANG EXTRACT GRAN also known as anything else?

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is also known as standard code for item: 200005676.

What development phase is SIHOGAYONGGOLMORYU TANG EXTRACT GRAN in?

SIHOGAYONGGOLMORYU TANG EXTRACT GRAN is FDA-approved (marketed).

Manufacturer: Korea Health Industry Development Institute — full pipeline
Also known as: standard code for item: 200005676
Compare: SIHOGAYONGGOLMORYU TANG EXTRACT GRAN vs similar drugs
Pricing: SIHOGAYONGGOLMORYU TANG EXTRACT GRAN cost, discount & access